Cholesterol, Inflammasomes, and Atherogenesis

Current Cardiovascular Risk Reports

Volumn 6, Issue 1, 2012, Pages 45-52

  Ordovas Montanes, Jose M ^a   Ordovas, Jose M ^b,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b TUFTS UNIVERSITY   (United States)

^c CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^d IMDEA FOOD INSTITUTE   (Spain)

Author keywords

Atherogenesis; Cardiovascular diseases; Cholesterol; Inflammasome; Inflammation

Indexed keywords

AMYLIN; AMYLOID A PROTEIN; C REACTIVE PROTEIN; CD14 ANTIGEN; CD36 ANTIGEN; CHOLESTEROL; CRYOPYRIN; G PROTEIN COUPLED RECEPTOR 120; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; PROTEIN MD 2; PURINERGIC P2X RECEPTOR; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; THIOREDOXIN INTERACTING PROTEIN; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 9;

ABDOMINAL AORTA ANEURYSM; ATHEROGENESIS; ATHEROSCLEROSIS; CARDIOVASCULAR RISK; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; GENETIC ASSOCIATION; GENETICS; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 84873813804     PISSN: 19329520     EISSN: 19329563     Source Type: Journal    
DOI: 10.1007/s12170-011-0212-2     Document Type: Review

References (56)

1. Libby P. Inflammation in atherosclerosis. Nature. 2002; 420: 868-74.
2. Hansson GK, Hermansson A. The immune system in atherosclerosis. Nat Immunol. 2011; 12: 204-12.
3. Moore KJ, Tabas I. Macrophages in the pathogenesis of atherosclerosis. Cell. 2011; 145: 341-55.
4. Latz E. The inflammasomes: mechanisms of activation and function. Curr Opin Immunol. 2010; 22: 28-33.
5. Schroder K, Tschopp J. The Inflammasomes. Cell. 2010; 140: 821-32.
6. • Duewell P, et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature. 2010; 464: 1357-61. This the seminal article linking NLRP3 to sensing damage induced by cholesterol crystals and playing a role in the progression of atherosclerosis.
7. Barton GM, Kagan JC. A cell biological view of Toll-like receptor function: regulation through compartmentalization. Nat Rev Immunol. 2009; 9: 535-42.
8. Chen GY, Nuñez G. Sterile inflammation: sensing and reacting to damage. Nat Rev Immunol. 2010; 10: 826-37.
9. Curtiss LK, Tobias PS. Emerging role of Toll-like receptors in atherosclerosis. The Journal of Lipid Research. 2008; 50: S340-5.
10. Lundberg AM, Hansson GK. Innate immune signals in atherosclerosis. Clin Immunol. 2010; 134: 5-24.
11. Stutz A, Golenbock DT, Latz E. Inflammasomes: too big to miss. J Clin Invest. 2009; 119: 3502-11.
12. Wright SD et al. Infectious agents are not necessary for murine atherogenesis. J Exp Med. 2000; 191: 1437-41.
13. Miller YI. Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells. J Biol Chem. 2002; 278: 1561-8.
14. • Stewart CR, et al. CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer. Nat Immunol. 2009; 11: 155-61. This is a description of a novel trimeric receptor for oxidized LDL, which has great relevance for understanding how endogenous ligands can provide proinflammatory signals.
15. Bae YS et al. Macrophages generate reactive oxygen species in response to minimally oxidized low-density lipoprotein: toll-like receptor 4- and spleen tyrosine kinase-dependent activation of NADPH oxidase 2. Circ Res. 2009; 104: 210-8.
16. Michelsen KS et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. PNAS. 2004; 101: 10679-84.
17. Shi H et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006; 116: 3015-25.
18. Kim F et al. Toll-like receptor-4 mediates vascular inflammation and insulin resistance in diet-induced obesity. Circ Res. 2007; 100: 1589-96.
19. Seimon TA et al. Combinatorial pattern recognition receptor signaling alters the balance of life and death in macrophages. PNAS. 2006; 103: 19794-9.
20. Seimon TA et al. Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress. Cell Metabol. 2010; 12: 467-82.
21. Lee JY. Differential modulation of Toll-like receptors by fatty acids: preferential inhibition by n-3 polyunsaturated fatty acids. J Lipid Res. 2002; 44: 479-86.
22. Weatherill AR et al. Saturated and polyunsaturated fatty acids reciprocally modulate dendritic cell functions mediated through TLR4. J Immunol. 2005; 174: 5390-7.
23. Joosten LAB et al. Engagement of fatty acids with toll-like receptor 2 drives interleukin-1β production via the ASC/caspase 1 pathway in monosodium urate monohydrate crystal-induced gouty arthritis. Arthritis Rheum. 2010; 62: 3237-48.
24. • Da Young Oh, et al. GPR120 Is an Omega-3 Fatty Acid Receptor Mediating Potent Anti-inflammatory and Insulin-Sensitizing Effects. Cell. 2010; 142: 687-98. This article identifies a receptor that is expressed on macrophages that can mediate the inflammatory effects of omega-3 fatty acids.
25. Kiechl S et al. Toll-like receptor 4 polymorphisms and atherogenesis. NEJM. 2002; 347: 185-92.
26. Noel SE et al. Variants of the CD36 gene and metabolic syndrome in Boston Puerto Rican adults. Atherosclerosis. 2010; 211: 210-5.
27. Osgood D et al. Genetic variation at the scavenger receptor class B type I gene locus determines plasma lipoprotein concentrations and particle size and interacts with type 2 diabetes: the Framingham study. J Clin Endocrinol Metab. 2003; 88: 2869-79.
28. Yajima N et al. Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice. Circulation. 2008; 117: 3079-87.
29. Martinon F et al. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature. 2006; 440: 237-41.
30. Dostert C et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science. 2008; 320: 674-7.
31. Hornung V et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol. 2008; 9: 847-56.
32. Madamanchi NR, Runge MS. Mitochondrial dysfunction in atherosclerosis. Circ Res. 2007; 100: 460-73.
33. Rajamäki K et al. Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation. PLoS One. 2010; 5: e11765.
34. • Menu P, et al. Atherosclerosis in ApoE-deficient mice progresses independently of the NLRP3 inflammasome. 2011; 2: e137-4. This article suggests that the NLRP3 inflammasome may not play a role in atherogenesis in an ApoE-deficient mouse model.
35. Khallou-Laschet J et al. Macrophage plasticity in experimental atherosclerosis. PLoS One. 2010; 5: e8852.
36. Baitsch D et al. Apolipoprotein E induces antiinflammatory phenotype in macrophages. Arterioscler Thromb Vasc Biol. 2011; 31: 1160-8.
37. Feig JE et al. HDL promotes rapid atherosclerosis regression in mice and alters inflammatory properties of plaque monocyte-derived cells. PNAS. 2011; 108: 6166-7171.
38. Freigang S et al. Nrf2 is essential for cholesterol crystal-induced inflammasome activation and exacerbation of atherosclerosis. Eur J Immunol. 2011; 41: 2040-51.
39. Zhou R, Yazdi AS, Menu P, Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature. 2010; 469: 221-5.
40. Bauernfeind F et al. Cutting edge: reactive oxygen species inhibitors block priming, but not activation, of the NLRP3 inflammasome. J Immunol. 2011; 187: 613-7.
41. Wen H, et al. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nature Publishing Group 1-9 (2011). doi: 10. 1038/ni. 2022.
42. • Vandanmagsar B, et al. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med. 2011; 17: 179-88. This article links the NLRP3 inflammasome both in humans and mice to diseases falling under the umbrella of metabolic syndrome.
43. Zhou R, Tardivel A, Thorens B, Choi I, Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nature Publishing Group. 2009; 11: 136-40.
44. Masters SL et al. Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nature Publishing Group. 2010; 11: 897-904.
45. NLRP3 is necessary for IL1 release in response to hyaluronan endogenous trigger. 1-10 (2009).
46. Niemi K et al. Serum amyloid A activates the NLRP3 inflammasome via P2X7 receptor and a cathepsin B-sensitive pathway. J Immunol. 2011; 186: 6119-28.
47. Papin S et al. The SPRY domain of Pyrin, mutated in familial Mediterranean fever patients, interacts with inflammasome components and inhibits proIL-1β processing. Cell Death Differ. 2007; 14: 1457-66.
48. Chae JJ et al. Gain-of-function pyrin mutations induce NLRP3 protein-independent interleukin-1& beta; activation and severe autoinflammation in mice. Immunity. 2011; 34: 755-68.
49. Özçakar ZB, Yalçi{dotless}nkaya F. Vascular comorbidities in familial Mediterranean fever. Rheumatol Int. 2011; 31: 1275-81.
50. Dehghan A et al. Meta-analysis of genome-wide association studies in > 80 000 subjects identifies multiple Loci for C-reactive protein levels. Circulation. 2011; 123: 731-8.
51. Dehghan A et al. Association of novel genetic loci with circulating fibrinogen levels: a genome-wide association study in 6 population-based cohorts. Circulation: Cardiovascular Genetics. 2009; 2: 125-33.
52. Wassel CL et al. Association of genomic loci from a cardiovascular gene SNP array with fibrinogen levels in European Americans and African-Americans from six cohort studies: the Candidate Gene Association Resource (CARe). Blood. 2011; 117: 268-75.
53. Roberts RL et al. Interaction of the inflammasome genes CARD8 and NLRP3 in abdominal aortic aneurysms. Atherosclerosis. 2011; 218: 123-6.
54. Stokes L et al. Two haplotypes of the P2X7 receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1 secretion. FASEB J. 2010; 24: 2916-27.
55. Palomino-Doza J et al. Ambulatory blood pressure is associated with polymorphic variation in P2X receptor genes. Hypertension. 2008; 52: 980-5.
56. Nakajima K et al. Exercise effects on methylation of ASC gene. Int J Sports Med. 2010; 31(9): 671-5.